Modulation of the Bovine Delayed-Type Hypersensitivity Responses to Defined Mycobacterial Antigens by a Synthetic Bacterial Lipopeptide

Infection and Immunity

Volumn 71, Issue 11, 2003, Pages 6420-6425

  Whelan, A O ^a   Hope, J C ^b   Howard, C J ^b   Clifford, D ^a   Hewinson, R G ^a   Vordermeier, H M ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EARLY SECRETORY ANTIGENIC TARGET 6; LIPOPEPTIDE; MPB64 ANTIGEN; MPB83 ANTIGEN; MYCOBACTERIUM ANTIGEN; PEPTIDE; PROTEIN; PROTEIN DERIVATIVE; REAGENT; RECOMBINANT ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD EXAMINATION; CATTLE DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MONOCYTE; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; SKIN TEST;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CATTLE; GUINEA PIGS; HYPERSENSITIVITY, DELAYED; LIPOPROTEINS; MYCOBACTERIUM BOVIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242349632     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.11.6420-6425.2003     Document Type: Article

References (47)

1. Andersen, A. B., L. Ljungqvist, K. Haslov, and M. W. Bentzon. 1991. MPB 64 possesses 'tuberculosis-complex'-specific B- and T-cell epitopes. Scand. J. Immunol. 34:365-372.
2. Askenase, P. W., S. Bursztajn, M. D. Gershon, and R. K. Gershon. 1980. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 152:1358-1374.
3. Bekiererkunst, A. 1984. Adjuvanticity of mycobacteria and their glycolipid components, wax D and cord factor, p. 761-786. In G. P. Kubica and W. Kubica (ed.), The mycobacteria: a sourcebook, part B. Marcel Dekker Inc., New York, N.Y.
4. ++ monocytes are a major source of TNF. J. Immunol. 168:3536-3542.
5. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-736.
6. Bryan, L. A., P. J. Griebel, D. M. Haines, W. C. Davis, and J. R. Allen. 1988. Immunocytochemical identification of bovine Langerhans cells by use of a monoclonal antibody directed against class II MHC antigens. J. Histochem. Cytochem. 36:991-995.
7. Buddle, B. M., G. W. de Lisle, A. Pfeffer, and F. E. Aldwell. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130.
8. Buddle, B. M., N. A. Parlane, D. L. Keen, F. E. Aldwell, J. M. Pollock, K. Lightbody, and P. Andersen. 1999. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin. Diagn. Lab. Immunol. 6:1-5.
9. Chu, C. Q., M. Field, E. Andrew, D. Haskard, M. Feldmann, and R. N. Maini. 1992. Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin. Exp. Immunol. 90:522-529.
10. Cockle, P. J., S. V. Gordon, A. Lalvani, B. M. Buddle, R. G. Hewinson, and H. M. Vordermeier. 2002. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect. Immun. 70:6996-7003.
11. Elhay, M. J., T. Oettinger, and P. Anderson. 1998. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect. Immun. 66:3454-3456.
12. European Council. 1997. Tuberculin purified protein derivative, bovine, p. 1680-1681. In European pharmacopoeia, 3rd ed. Council of Europe Publishing, Strasbourg, France.
13. European Economic Community. 1980. EEC directive 80/219, amending directive 64/432 annexe B. Off. J. Eur. Union L047:25-32.
14. Fifis, T., L. A. Corner, J. S. Rothel, and P. R. Wood. 1994. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens. Scand. J. Immunol. 39:267-274.
15. Fifis, T., P. Plackett, L. A. Corner, and P. R. Wood. 1989. Purification of a major Mycobacterium bovis antigen for the diagnosis of bovine tuberculosis. Scand. J. Immunol. 29:91-101.
16. Gershon, R. K., P. W. Askenase, and M. D. Gershon. 1975. Requirement for vasoactive amines for production of delayed-type hypersensitivity skin reactions. J. Exp. Med. 142:732-747.
17. Godlewski, A., J. Dobek-Smiech, and A. Zielinski. 1996. Comparative studies on mast cell distribution in the skin of humans and laboratory animals. A preliminary report. Folia Histochem. Cytobiol. 34(Suppl. 1):47-48.
18. Haga, S., R. Yamaguchi, S. Nagai, K. Matsuo, A. Yamazaki, and R. M. Nakamura. 1995. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG. J. Leukoc. Biol. 57:221-225.
19. Hardie, R. M., and J. M. Watson. 1992. Mycobacterium bovis in England and Wales: past, present and future. Epidemiol. Infect. 109:23-33.
20. Haslov, K., A. Andersen, S. Nagai, A. Gottschau, T. Sorensen, and P. Andersen. 1995. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect. Immun. 63:804-810.
21. Hauschildt, S., P. Hoffmann, H. U. Beuscher, G. Dufhues, P. Heinrich, K. H. Wiesmuller, G. Jung, and W. G. Bessler. 1990. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur. J. Immunol. 20:63-68.
22. Hope, J. C., L. S. Kwong, G. Entrican, S. Wattegedera, H. M. Vordermeier, P. Sopp, and C. J. Howard. 2002. Development of detection methods for ruminant interleukin (IL)-12. J. Immunol. Methods 266:117-126.
23. + T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guerin vaccinated and nonvaccinated cattle. Scand. J. Immunol. 52:285-291.
24. Jenkins, M. K., A. Khoruts, E. Ingulli, D. L. Mueller, S. J. McSorley, R. L. Reinhardt, A. Itano, and K. A. Pape. 2001. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:23-45.
25. Kalaaji, A. N., K. McCullough, and J. B. Hay. 1989. The enhancement of lymphocyte localization in skin sites of sheep by tumor necrosis factor alpha. Immunol. Lett. 23:143-147.
26. Kazwala, R. R., C. J. Daborn, J. M. Sharp, D. M. Kambarage, S. F. H. Jiwa, and N. A. Mbembati. 2001. Isolation of Mycobacterium bovis from human cases of cervical adenitis in Tanzania: a cause for concern? Int. J. Tuber. Lung Dis. 5:87-91.
27. Kidane, D., J. O. Olobo, A. Habte, Y. Negesse, A. Aseffa, G. Abate, M. A. Yassin, K. Bereda, and M. Harboe. 2002. Identification of the causative organism of tuberculous lymphadenitis in Ethiopia by PCR. J. Clin. Microbiol. 40:4230-4234,
28. Kuther, K., L. Audige, P. Kube, and M. Welle. 1998. Bovine mast cells: distribution, density, heterogeneity, and influence of fixation techniques. Cell Tissue Res. 293:111-119.
29. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-33425.
30. Llandi, S. 1984. Production and standardisation of tuberculin, p. 505-535. In G. P. Kubica and W. Kubica (ed.), The mycobacteria: a sourcebook, part A. Marcel Dekker Inc., New York, N.Y.
31. Miura, K., S. Nagai, M. Kinomoto, S. Haga, and T. Tokunaga. 1983. Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70. Infect. Immun. 39:540-545.
32. Monaghan, M. L., M. L. Doherty, J. D. Collins, J. F. Kazda, and P. J. Quinn. 1994. The tuberculin test. Vet. Microbiol. 40:111-124.
33. Muller, M. R., S. D. Pfannes, M. Ayoub, P. Hoffmann, W. G. Bessler, and K. Mittenbuhler. 2001. Immunostimulation by the synthetic lipopeptide P3CSK4: TLR4-independent activation of the ERK1/2 signal transduction pathway in macrophages. Immunology 103:49-60.
34. Nagai, S., K. Miura, T. Tokunaga, and M. Harboe. 1986. MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo. Dev. Biol. Stand. 58:511-516.
35. Pollock, J. M., and P. Andersen. 1997. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J. Infect. Dis. 175:1251-1254.
36. Pollock, J. M., R. M. Girvin, K. A. Lightbody, R. A. Clements, S. D. Neill, B. M. Buddle, and P. Andersen. 2000. Assessment of defined antigens for the diagnosis of bovine tuberculosis in skin test-reactor cattle. Vet. Rec. 146:659-665.
37. Radunz, B. L., and A. W. Lepper. 1985. Suppression of skin reactivity to bovine tuberculin in repeat tests. Aust. Vet. J. 62:191-194.
38. Sueki, H., C. Gammal, K. Kudoh, and A. M. Kligman. 2000. Hairless guinea pig skin: anatomical basis for studies of cutaneous biology. Eur. J. Dermatol. 10:357-364.
39. Teunissen, M. B. 1992. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem. J. 24:697-716.
40. Tokunaga, T., T. Yamamoto, and S. Yamamoto. 1999. How BCG led to the discovery of immunostimulatory DNA. Jpn. J. Infect. Dis. 52:1-11.
41. van Pinxteren, L. A., P. Ravn, E. M. Agger, J. Pollock, and P. Andersen. 2000. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin. Diagn. Lab. Immunol. 7:155-160.
42. von den Esche, U., M. Ayoub, S. D. Pfannes, M. R. Muller, M. Huber, K. H. Wiesmuller, T. Loop, M. Humar, K. F. Fischbach, M. Strunkelnberg, P. Hoffmann, W. G. Bessler, and K. Mittenbuhler. 2000. Immunostimulation by bacterial components. I. Activation of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4. Int. J. Immunopharmacol. 22:1093-1102.
43. Vordermeier, H. M., P. C. Cockle, A. Whelan, S. Rhodes, N. Palmer, D. Bakker, and R. G. Hewinson. 1999. Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle. Clin. Diagn. Lab. Immunol. 6:675-682.
44. Vordermeier, H. M., A. Whelan, P. J. Cockle, L. Farrant, N. Palmer, and R. G. Hewinson. 2001. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol. 8:571-578.
45. Wiesmuller, K. H., W. Bessler, and G. Jung. 1983. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe-Seyler's Z. Physiol. Chem. 364:593-606.
46. Wilcke, J. T., B. N. Jensen, P. Ravn, A. B. Andersen, and K. Haslov. 1996. Clinical evaluation of MPT-64 and MPT-59, two proteins secreted from Mycobacterium tuberculosis, for skin test reagents. Tuber. Lung. Dis. 77:250-256.
47. Wu, H. C., and T. M. Tokunaga. 1986. Biogenesis of lipoproteins in bacteria. Curr. Top. Microbiol. Immunol. 125:127-157.